LMB 1
Alternative Names: B3-LysPE38Latest Information Update: 25 Sep 2006
At a glance
- Originator National Institutes of Health (USA)
- Class Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Solid tumours